Tweet
This is a detailed article in pdf form from the Hematology Journal (2004) about long-term care after a stem cell transplant. Even if the HSCT zaps down your multiple sclerosis, there are still other hurdles and potential consequences to consider with the treatment.
Introduction
Large numbers of patients now survive long term following stem-cell transplantation (SCT). The late clinical effects of SCT, particularly secondary malignancies, are therefore of major concern in the 21st century. Nonmalignant late effects are heterogeneous, and although often not life-threatening, they significantly impair quality of life.
http://online.haematologica.org/thj/2004/6200420a.pdf
Introduction
Large numbers of patients now survive long term following stem-cell transplantation (SCT). The late clinical effects of SCT, particularly secondary malignancies, are therefore of major concern in the 21st century. Nonmalignant late effects are heterogeneous, and although often not life-threatening, they significantly impair quality of life.
http://online.haematologica.org/thj/2004/6200420a.pdf